SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 9, 2000, Pages 3486-3492

Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: A north central cancer treatment group study

(11) Burch, P A a Block, M a Schroeder, G a Kugler, J W a Sargent, D J a Braich, T A a Mailliard, J A a Michalak, J C a Hatfield, A K a Wright, K a Kuross, S A a

a MAYO CLINIC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OCTREOTIDE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LEUKOPENIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANCREAS CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, PANCREATIC DUCTAL; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATIC NEOPLASMS; SURVIVAL RATE;

EID: 0033822686 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (31)

References (52)

1
- 0033006836
- Cancer statistics 1999
- (1999) CA Cancer J. Clin. , vol.49 , pp. 8-31
- Landis, S.H.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

2
- 0030895183
- Multimodal therapies in ductal pancreatic cancer. The future
- (1997) Int. J. Pancreatol. , vol.21 , pp. 71-82
- Link, K.H.¹ Gansauge, F.² Pillasch, J.³ Beger, H.G.⁴

3
- 0029943675
- Activity of gemcitabine in patients with advanced pancreatic carcinoma-a review
- (1996) Cancer (Phila.) , vol.78 , pp. 633-638
- Moore, M.¹

4
- 84944367593
- A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs. fluorouracil and doxorubicin vs. fluorouracil, doxorubicin, and mitomycin
- (1985) JAMA , vol.253 , pp. 2061-2067
- Cullinan, S.A.¹ Moertel, C.G.² Fleming, T.R.³ Rubin, J.R.⁴ Krook, J.E.⁵ Everson, L.K.⁶ Windschitl, H.E.⁷ Twito, D.I.⁸ Marschke, R.F.⁹ Foley, J.F.¹⁰ Pfeifle, D.M.¹¹ Barlow, J.F.¹²

5
- 0025360261
- A Phase III trial on the therapy of advanced pancreatic cancer. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
- (1990) Cancer (Phila.) , vol.65 , pp. 2207-2212
- Cullinan, S.¹ Moertel, C.G.² Wieand, H.S.³ Schutt, A.J.⁴ Krook, J.E.⁵ Foley, J.F.⁶ Norris, B.D.⁷ Kardinal, C.G.⁸ Tschetter, L.K.⁹ Barlow, J.F.¹⁰

6
- 0030054029
- Octreotide
- (1996) N. Engl. J. Med. , vol.334 , pp. 246-253
- Lamberts, S.W.J.¹ Van der Lely, A.J.² De Herder, W.W.³ Hofland, L.J.⁴

7
- 0020363575
- SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
- (1982) Life Sci. , vol.31 , pp. 1133-1140
- Bauer, W.¹ Briner, U.² Doepfner, W.³ Haller, R.⁴ Huguenin, R.⁵ Marbach, P.⁶ Petcher, T.J.⁷ Pless, J.⁸

8
- 0020580181
- Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones
- (1983) Proc. Natl. Acad. Sci. USA , vol.80 , pp. 1078-1082
- Redding, T.W.¹ Schally, A.V.²

9
- 0021990503
- A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth
- (1985) Acta Endocrinol. (Copenh) , vol.109 , pp. 108-114
- Reubi, J.C.¹

10
- 0023893674
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue
- (1988) Biochem. Biophys. Res. Commun. , vol.153 , pp. 81-86
- Taylor, J.E.¹ Bogden, A.E.² Moreau, J.P.³ Coy, D.H.⁴

11
- 0023130974
- Direct inhibitory effects of somatostailn (analogues) on the growth of human breast cancer cells
- (1987) Cancer Res. , vol.47 , pp. 1566-1570
- Setyono-Han, B.¹ Henkelman, M.S.² Foekens, J.A.³ Klijn, J.G.M.⁴

12
- 0026772390
- Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination
- (1992) Breast Cancer Res. Treat. , vol.21 , pp. 181-192
- Szepeshazi, K.¹ Milovanovic, S.² Lapis, K.³ Groot, K.⁴ Schally, A.V.⁵

13
- 0025863280
- Somatostatin analogue RC-160 inhibits the growth of transplanted colon cancer in rats
- (1991) Int. J. Cancer , vol.47 , pp. 765-770
- Qin, Y.¹ Schally, A.V.² Willems, G.³

14
- 0028077628
- Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo
- (1994) Cancer Res. , vol.54 , pp. 5895-5901
- Pinski, J.¹ Schally, A.V.² Halmos, G.³ Szepeshazi, K.⁴ Groot, K.⁵

15
- 0024600650
- Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase
- (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 2003-2007
- Liebow, C.¹ Reilly, C.² Serrano, M.³ Schally, A.V.⁴

16
- 2842582654
- Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin
- (1989) Proc. Natl. Acad. Sci. USA , vol.86 , pp. 1643-1647
- Szende, B.¹ Zalatnai, A.² Schally, A.V.³

17
- 0025055752
- Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice
- (1990) Pancreas , vol.5 , pp. 151-157
- Poston, G.J.¹ Townsend, C.M.² Rajaraman, S.³ Thompson, J.C.⁴ Singh, P.⁵

18
- 0027473092
- Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice
- (1993) Pancreas , vol.8 , pp. 89-97
- Radulovic, S.¹ Comaru-Schally, A.M.² Milovanovic, S.³ Schally, A.V.⁴

19
- 0025308907
- Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancer in hamsters. Events that accompany tumor recession
- (1990) Cancer (Phila.) , vol.65 , pp. 2279-2290
- Szende, B.¹ Srkalovic, G.² Schally, A.V.³ Lapis, K.⁴ Groot, K.⁵

20
- 0023851818
- Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995
- (1988) Am. J. Surg. , vol.155 , pp. 29-35
- Upp, J.R.¹ Olson, D.² Poston, G.J.³ Alexander, R.W.⁴ Townsend, C.M.⁵ Thompson, J.C.⁶

21
- 0028906832
- Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate
- (1995) Int. J. Cancer , vol.60 , pp. 694-700
- Qin, Y.¹ Ertl, T.² Groot, K.³ Horvath, J.⁴ Cai, R.Z.⁵ Schally, A.V.⁶

22
- 0021327318
- Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones
- (1984) Proc. Natl. Acad. Sci. USA , vol.81 , pp. 248-252
- Redding, T.W.¹ Schally, A.V.²

23
- 0030728565
- Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine
- (1997) Int. J. Pancreatol. , vol.22 , pp. 81-93
- Rosenberg, L.¹

24
- 0031941299
- Mechanisms of antineoplastic action of somatostatin analogs
- (1998) Proc. Soc. Exp. Biol. Med. , vol.217 , pp. 143-152
- Pollak, M.N.¹ Schally, A.V.²

25
- 0028203634
- Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2
- (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 2315-2319
- Buscail, L.¹ Delesque, N.² Esteve, J.P.³ Saint-Laurent, N.⁴ Prats, H.⁵ Clerc, P.⁶ Robberecht, P.⁷ Bell, G.I.⁸ Liebow, C.⁹ Schally, A.V.¹⁰ Vaysse, N.¹¹ Susini, C.¹²

26
- 0031019186
- Inhibition of experimental angiogenesis by the somatostatin analogue octreoilde acetate (SMS 201-995)
- (1997) Clin. Cancer Res. , vol.3 , pp. 265-272
- Danesi, R.¹ Agen, C.² Benelli, U.³ Di Paolo, A.⁴ Nardini, D.⁵ Bocci, G.⁶ Basolo, F.⁷ Campagni, A.⁸ Basolo, F.⁹ Campagni, A.¹⁰ Tacca, M.D.¹¹

27
- 0001246436
- An odyssey in the land of small tumors
- (1987) J. Clin. Oncol. , vol.5 , pp. 1503-1522
- Moertel, C.G.¹

28
- 0027215419
- Somatostatin analogue Phase I trials in neuroendocrine neoplasms
- (1993) Acta Oncol. , vol.32 , pp. 217-223
- Anthony, L.¹ Johnson, D.² Hande, K.³ Shaff, M.⁴ Winn, S.⁵ Krozely, M.⁶ Oates, J.⁷

29
- 0026500158
- Somatostatin and growth hormone regulation in cancer
- (1992) Biotherapy , vol.4 , pp. 31-36
- Manni, A.¹

30
- 0027216975
- Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer
- (1993) Pancreas , vol.8 , pp. 540-545
- Friess, H.¹ Buchler, M.² Beglinger, C.³ Weber, A.⁴ Kunz, J.⁵ Fritsch, K.⁶ Dennler, H.J.⁷ Berger, H.G.⁸

31
- 0027980912
- Stopping when the experimental regimen does not appear to help
- (1994) Star. Med. , vol.13 , pp. 1453-1458
- Wieand, S.¹ Schroeder, G.² O'Fallon, J.³

32
- 33845382806
- Nonparametric estimation from incomplete abservations
- (1985) J. Am. Stat. Assoc. , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

33
- 84959801619
- Statistical aspects of the analysis of data from retrospective studies of disease
- (1959) J. Natl. Cancer Inst. , vol.22 , pp. 719-748
- Mantel, H.¹ Haenszel, W.²

34
- 0000336139
- Regression models and life tables
- (1972) J. R. Stat. Soc. B , vol.34 , pp. 187-202
- Cox, D.R.¹

35
- 0028105803
- Role of octreotide in the treatment of pancreatic cancer
- (1994) Digestion , vol.55 , Issue.SUPPL. 1 , pp. 48-51
- Ebert, M.¹ Friess, H.² Beger, H.G.³ Buchler, M.W.⁴

36
- 0025086788
- Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: A Phase II study including endocrine effects
- (1990) Br. J. Cancer , vol.62 , pp. 627-630
- Klijn, J.G.M.¹ Hoff, A.M.² Planting, A.S.T.³ Verweij, J.⁴ Kok, T.⁵ Lamberts, S.W.J.⁶ Portengen, H.⁷ Foekens, J.A.⁸

37
- 0007966061
- A Phase II study of octreotide (SMS) in advanced pancreatic cancer
- (1994) Proc. Am. Soc. Clin. Oncol. , vol.13 , pp. 214
- Buchler, M.¹ Sulkowski, U.² Pederzoli, P.³ Arnold, R.⁴ Dinse, P.⁵ Mietlowski, W.⁶ Israel, R.⁷

38
- 0028281467
- Somatostatin and the treatment of pancreatic cancer
- (1994) Ann. R. Coll. Surg. Engl. , vol.76 , pp. 172-174
- Poston, G.J.¹

39
- 0026501635
- Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study
- (1992) Cancer (Phila.) , vol.69 , pp. 648-650
- Canobbio, L.¹ Boccardo, F.² Cannata, D.³ Gallotti, P.⁴ Epis, R.⁵

40
- 0031060236
- Octreotide combined with goserelin in the therapy of advanced pancreatic cancer: Results of a pilot study and review of the literature
- (1997) J. Cancer Res. Clin. Oncol. , vol.123 , pp. 45-52
- Fazeny, B.¹ Baur, M.² Prohaska, M.³ Hudec, M.⁴ Kremnitzer, M.⁵ Meryn, S.⁶ Huber, H.⁷ Grunt, T.⁸ Tuchmann, A.⁹ Dittrich, C.¹⁰

41
- 0007964865
- Hormonal therapy of pancreatic carcinoma with GNRH and somatostatin analogs
- (1991) Proc. Am. Soc. Clin. Oncol. , vol.10 , pp. 302
- Suri, P.¹ Lipton, A.² Harvey, H.A.³ Wyszynski, E.⁴ Dixon, R.⁵ Hamilton, R.W.⁶

42
- 0028859242
- Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas
- (1995) Cancer (Phila.) , vol.75 , pp. 23-28
- Rosenberg, L.¹ Barkun, A.N.² Denis, M.H.³ Pollak, M.⁴

43
- 0028878559
- A randomised trial of octreotide vs. best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy
- (1995) Br. J. Cancer , vol.71 , pp. 97-101
- Cascinu, S.¹ Del Ferro, E.² Catalano, G.³

44
- 0000048607
- Phase 3 trial of SMS 201-995 pa LAR (SMS pa LAR) vs. placebo in unresectable stage II, III and IV pancreatic cancer
- (1998) Proc. Am. Soc. Clin. Oncol. , vol.17 , pp. 257
- Pederzoli, P.¹ Maurer, U.² Vollmer, K.³ Buechler, M.⁴ Kjaeve, J.⁵ Van Cutsem, E.⁶ Di Carlo, V.⁷ Stauder, H.⁸ Bergan, A.⁹ Ebert, M.¹⁰ Kiese, B.¹¹ Raymond, M.C.¹² Kay, A.¹³

45
- 0027043157
- Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone)
- (1992) Am. J Surg. , vol.164 , pp. 348-353
- Huguier, M.¹ Samama, G.² Testart, J.³ Mauban, S.⁴ Fingerhut, A.⁵ Nassar, J.⁶ Houry, S.⁷ Jaeck, D.⁸ De Mestier, P.⁹ Favre, J.P.¹⁰ Michot, F.¹¹ Vidrequin, A.¹² Mantion, G.¹³ Veyrieres, M.¹⁴ Fourtanier, G.¹⁵ Lointier, P.¹⁶ Gignoux, M.¹⁷

46
- 0000048607
- Phase 3 trial of SMS 201-995 pa LAR (SMS pa LAR) and continuous infusion 5-FU in unresectable stage II, III and IV pancreatic cancer
- (1998) Proc. Am. Soc. Clin. Oncol. , vol.17 , pp. 257
- Roy, A.¹ Jacobs, A.² Bukowski, R.³ Cunningham, D.⁴ Hamm, J.⁵ Schlag, P.M.⁶ Rosen, P.⁷ Francois, E.⁸ Finley, G.⁹ Kipton, A.¹⁰ Bruckner, H.¹¹ Haller, D.¹² Conroy, T.¹³ Goel, R.¹⁴ Price, P.¹⁵ Smith, G.¹⁶ Mietlowski, W.¹⁷ Linnartz, R.¹⁸ Russo, D.¹⁹ Kay, A.²⁰ more..

47
- 0029822870
- Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide
- (1996) Surgery , vol.120 , pp. 234-241
- Fisher, W.E.¹ Muscarella, P.² O'Dorisio, T.M.³ O'Dorisio, M.S.⁴ Kim, J.A.⁵ Doran, T.A.⁶ Sabourin, C.L.⁷ Schirmer, W.J.⁸

48
- 0026794573
- Human pancreatic cancer cell lines do not express receptors for somatostatin
- (1992) Br. J. Cancer , vol.66 , pp. 483-487
- Gillespie, J.¹ Poston, G.J.² Schachter, M.³ Guillou, P.J.⁴

49
- 0023713829
- Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas
- (1988) Gastroenterology , vol.95 , pp. 760-763
- Reubi, J.C.¹ Horisberger, U.² Essed, C.E.³ Jeekel, J.⁴ Klijn, J.G.H.⁵ Lamberts, S.W.J.⁶

50
- 0032542522
- Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer
- (1998) J. Natl. Cancer Inst. , vol.90 , pp. 322-324
- Fisher, W.E.¹ Doran, T.A.² Muscarella, P.³ Boros, L.G.⁴ Ellison, E.C.⁵ Schirmer, W.J.⁶

51
- 0032539609
- Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
- (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 1794-1799
- Nagy, A.¹ Schally, A.V.² Halmos, G.³ Armatis, P.⁴ Cai, R.Z.⁵ Csernus, V.⁶ Kovacs, M.⁷ Koppan, M.⁸ Szepeshazi, K.⁹ Kahan, Z.¹⁰

52
- 0031025637
- sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells
- (1997) Cancer Res. , vol.57 , pp. 956-962
- Delesque, N.¹ Buscail, L.² Esteve, J.P.³ Saint-Laurent, N.⁴ Muller, C.⁵ Weckbecker, G.⁶ Bruns, C.⁷ Vaysse, N.⁸ Susini, C.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.